CAR-T Cell Therapy market Research Report by 2022, Forecast till 2035

  • CAR-T cell therapies have been shown to enable complete disease remission, omitting the need for any further treatment. Several studies have proven the efficacy of these therapy candidates.

    Driven by the ongoing pace of innovation and sufficient financial support from investors, the CAR-T cell therapy market is anticipated to witness substantial growth in the foreseen future

    The financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:

    • Target indication(s)
    • Non-Hodgkin's Lymphoma
    • multiple myeloma
    • Acute Lymphoblastic Leukemia
    • Chronic Lymphocytic Leukemia
    • Hodgkin's lymphoma
    • Acute myeloid leukemia
    • Ovarian Cancer
    • Generalized myasthenia gravis (MG)
    • Renal cell carcinoma
    • target antigen
    • CD19
    • BCMA
    • CD19/22
    • Others
    • Key Geographical Regions
    • NorthAmerica
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North Africa
    • rest of the world

    The Global CAR-T Cell Therapy Market (4 th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

    • Autolus
    • bluebird bio
    • Bristol Myers Squibb
    • Carsgene Therapeutics
    • Cellectis
    • Cellular Biomedicine Group
    • Gilead Sciences
    • Innovative Cellular Therapeutics
    • Kur Therapeutics
    • Noile Immune Biotech
    • Novartis
    • Shanghai GeneChem
    • Sinobioway Cell Therapy
    • Takara Bio
    • Wellington Zhaotai Therapies

    Table of Contents

    1. Preface

    2. Executive summary

    3. Introduction

    4. CAR-T Cell Therapies: Market Landscape

    5. Key Insights

    6. Clinical Trial ANALYSIS

    7. Key Opinion Leaders

    8. CAR-T Cell Therapy Profiles

    9. Partnerships And Collaborations

    10. Funding And Investment Analysis

    11. Patent Analysis

    12. Case Study: Cell Therapy Manufacturing

    13. Cost Price Analysis

    14. Market Forecast and Opportunity Analysis

    15. Promotional Analysis

    16. Company Profiles

    17. Concluding Remarks

    18. Executive Insights

    19. Appendix 1: Tabulated Data

    20. Appendix 2: List of Companies and Organizations

    Get more details on the CAR-T Cell Therapy Market report…therapies-market/269.html

    You may also be interested in the following titles:

    You may also like to learn what our experts are sharing in Roots educational series:

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


    ben johnson

    +1 (415) 800 3415

Letzte Aktivitäten

Jetzt mitmachen!

Sie haben noch kein Benutzerkonto auf unserer Seite? Registrieren Sie sich kostenlos und nehmen Sie an unserer Community teil!